Navigation Links
Media advisory: Brain cell injections may quiet epileptic seizures

More than two million people in the United States suffer from epilepsies, a group of neurological disorders caused by abnormal nerve cell firing in the brain which often produce debilitating seizures. Although anti-epileptic drugs and other therapies reduce seizures in about two-thirds of patients, the remaining one-third do not respond to any form of therapy and those who take drugs can experience harmful side effects. NIH funded researchers at the University of California at San Francisco used a mouse model of epilepsy to show that transplanting new born inhibitory nerve cells can quiet seizures. Inhibitory cells are one of two major nerve cell groups, the other being excitatory. Their results, published in Nature Neuroscience, show that injecting new inhibitory cells into the hippocampus in the brains of adult epileptic mice greatly reduced the occurrence of seizures and reversed some learning and memory problems associated with the disorder. Analysis of the mice brains suggested the new cells became fully incorporated into the brain regions where they were injected. The results support the idea that cell therapies may provide precise and novel ways to treat epilepsy and other neurological disorders.


Contact: Christopher Thomas
NIH/National Institute of Neurological Disorders and Stroke

Page: 1

Related biology news :

1. G protein-coupled receptor mediates the action of castor oil
2. NineSigma Launches NineSights, the Worlds First Open Innovation Social Media Destination for Innovation Seekers and Solution Providers
3. Media registration opens for Neuroscience 2012, worlds largest brain science meeting
4. Evermedia Group Announces 375% Increase in Revenue for Second Quarter 2012
5. Medbox, Inc. Releases Demo Video and Collateral Media Concerning How Their Systems Will Be Used in Massachusetts Medical Marijuana Dispensaries
6. Outside a vacuum: Model predicts movement of charged particles in complex media
7. Medbox, Inc. Featured in Multiple Media Stories in Massachusetts and California
8. BodyMedia & FitOrbit Up the Ante in Personalized Weight Loss
9. New report finds increase in media coverage of synthetic biology
10. Media invited: Biophysical Society Annual Meeting
11. Monitoring and robust induction of nephrogenic intermediate mesoderm from human iPSCs
Post Your Comments:
(Date:11/17/2015)... SOUTH EASTON, Mass. , Nov. 17, 2015 /PRNewswire/ ... "Company"), a leader in the development and sale of ... to the worldwide life sciences industry, today announced it ... closing of its $5 million Private Placement (the "Offering"), ... Offering to $4,025,000.  One or more additional closings are ...
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , an ... of clinical research, is pleased to announce that it will ... Trials (PCT) event, to be held November 17-19 in ... to view live demonstrations of iMedNet , ... how iMedNet has been able to deliver time ...
(Date:11/4/2015)... 2015 --> ... by Transparency Market Research "Home Security Solutions Market - Global ... - 2022", the global home security solutions market is expected to ... The market is estimated to expand at a CAGR ... 2022. Rising security needs among customers at homes, the ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... ... November 24, 2015 , ... In ... paramount. Insertion points for in-line sensors can represent a weak spot where leaking ... 781/784 series of retractable sensor housings , which are designed to tolerate extreme ...
(Date:11/24/2015)... HemoShear Therapeutics, LLC, a privately held ... disorders, announced today the appointment of H. ... (BOD). Mr. Watkins is the former president and ... and also served as the chairman of the ... Chairman and CEO of HemoShear Therapeutics. "The combination ...
(Date:11/23/2015)... Women with a certain type of lung nodule ... risk of lung cancer than men with similar nodules, according ... annual meeting of the Radiological Society of North ... --> Lung nodules are small masses of tissue ... based on their appearance on CT. Solid nodules are dense, ...
(Date:11/23/2015)... The royalty-free a greement ... develop daclatasvir for 112 low- and m ... --> --> The Medicines Patent Pool (MPP) ... signing an agreement with Bristol-Myers Squibb for daclatasvir, a novel ... of the HCV virus.  The royalty-free licence will enable generic ...
Breaking Biology Technology: